Effect of the USPSTF grade D recommendation against screening for prostate cancer on incident prostate cancer diagnoses in the United States

Journal of Urology

Volumn 194, Issue 6, 2015, Pages 1587-1593

  Barocas, Daniel A ^a   Mallin, Katherine ^b   Graves, Amy J ^a   Penson, David F ^a   Palis, Bryan ^b   Winchester, David P ^b   Chang, Sam S ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b AMERICAN COLLEGE OF SURGEONS   (United States)

Author keywords

diagnosis; guideline; mass screening; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; COLON CANCER; COMORBIDITY; GLEASON SCORE; HEALTH INSURANCE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MIDDLE AGED; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; UNITED STATES; BLOOD; CANCER STAGING; DELAYED DIAGNOSIS; DISEASE COURSE; EARLY DIAGNOSIS; INCIDENCE; LEGISLATION AND JURISPRUDENCE; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PREVENTIVE HEALTH SERVICE; PROSTATIC NEOPLASMS; STANDARDS; UNNECESSARY PROCEDURE; UTILIZATION; UTILIZATION REVIEW;

AGED; BIOMARKERS, TUMOR; DELAYED DIAGNOSIS; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; HUMANS; INCIDENCE; MALE; NEOPLASM STAGING; PREVENTIVE HEALTH SERVICES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; UNITED STATES; UNNECESSARY PROCEDURES; UTILIZATION REVIEW;

EID: 84947253272     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2015.06.075     Document Type: Article

References (27)

1. R. Chou, J.M. Croswell, T. Dana, and et al. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 155 2011 762
2. K. Lin, J.M. Croswell, H. Koenig, and et al. Prostate-specific antigen-based screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force 2011 Agency for Healthcare Research and Quality Rockville
3. V.A. Moyer U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 157 2012 120
4. R. Siegel, J. Ma, Z. Zou, and et al. Cancer statistics, 2014 CA Cancer J Clin 64 2014 9
5. G.L. Andriole, E.D. Crawford, R.L. Grubb, and et al. Mortality results from a randomized prostate-cancer screening trial N Engl J Med 360 2009 1310
6. F.H. Schröder, J. Hugosson, M.J. Roobol, and et al. Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320
7. R. Etzioni, A. Tsodikov, A. Mariotto, and et al. Quantifying the role of PSA screening in the US prostate cancer mortality decline Cancer Causes Control 19 2008 175
8. R. Gulati, A.B. Mariotto, S. Chen, and et al. Long-term projections of the harm-benefit trade-off in prostate cancer screening are more favorable than previous short-term estimates J Clin Epidemiol 64 2011 1412
9. P.C. Gøtzsche, and K.J. Jørgensen Screening for breast cancer with mammography Cochrane Database Syst Rev 2013 CD001877
10. P. Hewitson, P. Glasziou, L. Irwig, and et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult Cochrane Database Syst Rev 2007 CD001216
11. A. Aslani, B.J. Minnillo, G. Johnson, and et al. The impact of recent screening recommendations on prostate cancer screening in a large health care system J Urol 191 2014 1737
12. J.A. Cohn, C.E. Wang, J.C. Lakeman, and et al. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation Urol Oncol 32 2014 41.e23
13. B. Bhindi, M. Mamdani, G.S. Kulkarni, and et al. Impact of the U.S. Preventive Services Task Force Recommendations against PSA screening on prostate biopsy and cancer detection rates J Urol 193 2015 1519
14. K.Y. Bilimoria, A.K. Stewart, D.P. Winchester, and et al. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States Ann Surg Oncol 15 2008 683
15. R.A. Deyo, D.C. Cherkin, and M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613
16. A.V. D'Amico, R. Whittington, S.B. Malkowicz, and et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969
17. W.R. Shadish, T.D. Cook, and D.T. Campbell Experimental and Quasi-Experimental Designs for Generalized Causal Inference 2002 Houghton Mifflin Boston
18. A.K. Wagner, S.B. Soumerai, F. Zhang, and et al. Segmented regression analysis of interrupted time series studies in medication use research J Clin Pharm Ther 27 2002 299
19. S. Loeb, M.A. Bjurlin, J. Nicholson, and et al. Overdiagnosis and overtreatment of prostate cancer Eur Urol 65 2014 1046
20. A. Bill-Axelson, L. Holmberg, H. Garmo, and et al. Radical prostatectomy or watchful waiting in early prostate cancer N Engl J Med 370 2014 932
21. T.J. Wilt, M.K. Brawer, K.M. Jones, and et al. Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203
22. P.L. Nguyen, R. Whittington, S. Koo, and et al. The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinoma Cancer 103 2005 2053
23. R.K. Nam, M.A.S. Jewett, M.D. Krahn, and et al. Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy Can J Urol 10 2003 1891
24. P.C. Albertsen, J.A. Hanley, and J. Fine 20-Year outcomes following conservative management of clinically localized prostate cancer JAMA 293 2005 2095
25. D.A. Barocas, and D.F. Penson Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gap BJU Int 106 2010 322
26. Canadian Task Force on Preventive Health Care Recommendations on screening for prostate cancer with the prostate-specific antigen test CMAJ 186 2014 1225
27. H.B. Carter, P.C. Albertsen, M.J. Barry, and et al. Early detection of prostate cancer: AUA Guideline J Urol 190 2013 419.